Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Friday.
Kewaunee Scientific Price Performance
Shares of NASDAQ:KEQU opened at $37.09 on Friday. The company has a quick ratio of 2.00, a current ratio of 2.53 and a debt-to-equity ratio of 0.48. Kewaunee Scientific has a fifty-two week low of $16.51 and a fifty-two week high of $55.62. The firm has a 50-day simple moving average of $36.70 and a 200 day simple moving average of $41.43. The company has a market cap of $106.52 million, a PE ratio of 5.95 and a beta of 0.73.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last announced its quarterly earnings data on Wednesday, September 11th. The technology company reported $0.93 earnings per share for the quarter. Kewaunee Scientific had a net margin of 9.13% and a return on equity of 25.87%. The business had revenue of $48.39 million during the quarter.
Institutional Inflows and Outflows
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Recommended Stories
- Five stocks we like better than Kewaunee Scientific
- What Are Growth Stocks and Investing in Them
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How to Capture the Benefits of Dividend Increases
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.